81 studies found for:    "Dilated cardiomyopathy"
Show Display Options
Rank Status Study
21 Recruiting Mesenchymal Stem Cells for Idiopathic Dilated Cardiomyopathy
Condition: Primary Idiopathic Dilated Cardiomyopathy
Interventions: Other: bone marrow-derived MSCs injection;   Other: placebo intervention
22 Not yet recruiting Infusion Intracoronary of Mononuclear Autologous Adult no Expanded Stem Cells os Bone Marrow on Functional Recovery in Patients With Dilated Cardiomyopathy and Heart Failure.
Condition: Idiopathic Dilated Cardiomyopathy
Interventions: Drug: Infusion of autologous mononuclear bone marrow cells;   Drug: Placebo infusion
23 Terminated NORDIC: Nitric Oxide-Derived Oxidants and Regional Endothelial and Diastolic Dysfunction in Dilated Cardiomyopathy
Condition: Chronic Systolic Heart Failure (Dilated Cardiomyopathy)
Intervention:
24 Unknown  Danish ICD Study in Patients With Dilated Cardiomyopathy
Conditions: Heart Failure;   Dilated Cardiomyopathy;   Reduced LVEF
Interventions: Device: ICD;   Other: Optimal medical treatment
25 Completed Training Study to Evaluate the Benefit of Exercise for Patients With Chronic Heart Failure
Conditions: Dilated Cardiomyopathy;   Chronic Heart Failure
Intervention: Behavioral: Endurance training
26 Completed The Influence of Atorvastatin on the Parameters of Inflammation and the Function of Left Ventricle
Condition: Dilated Cardiomyopathy
Intervention: Drug: Tulip
27 Completed
Has Results
PUFAs and Left Ventricular Function in Heart Failure
Conditions: Dilated Cardiomyopathy;   Heart Failure
Interventions: Drug: n-3 PUFAs;   Drug: Placebo
28 Completed Resynchronization Therapy in Young Patients With and Without CHD
Conditions: Dilated Cardiomyopathy;   Pediatric
Intervention: Other: congestive heart failure patients
29 Recruiting Optimizing Left Ventricular Lead To Improve Cardiac Output
Conditions: Ischemic Congestive Cardiomyopathy;   Dilated Cardiomyopathy;   Congestive Heart Failure
Interventions: Procedure: Doppler flow measurement;   Procedure: standard implantation of the LV lead
30 Not yet recruiting 18F-deoxyglucose (FDG) PET-CMD
Condition: Patients With Idiopathic Dilated Cardiomyopathy
Intervention: Drug: 18F-deoxyglucose (FDG)
31 Unknown  Electrophysiologic and Morphologic Assessment of the Substrate to Guide Implantation of Defibrillators in Dilated Cardiomyopathy
Conditions: Dilated Cardiomyopathy;   Primary Prevention of Sudden Cardiac Death;   Implantable Cardioverter Defibrillator
Intervention:
32 Recruiting A Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy
Condition: LMNA-Related Dilated Cardiomyopathy
Intervention: Drug: ARRY-371797, p38 inhibitor; oral
33 Recruiting Prospective Becker-Heart-Study
Conditions: Dilated Cardiomyopathy;   Lef Ventricular Dysfunction;   Heart Failure
Intervention: Procedure: ECG, echocardiography, cardiac MRI, sera biomarkers
34 Completed Autologous Transplantation of Bone Marrow Mononuclear Stem-Cells by Mini-Thoracotomy
Condition: Dilated Cardiomyopathy
Intervention: Procedure: intramyocardial bone marrow stem cells implantation
35 Recruiting A Randomized, Controlled Study to Evaluate Algisyl-LVR™ as a Method of Left Ventricular Augmentation for Heart Failure
Conditions: Heart Failure;   Dilated Cardiomyopathy
Interventions: Device: Algisyl-LVR;   Drug: Standard medical therapy
36 Completed Safety and Feasibility of Algisyl-LVR™ as a Method of Left Ventricular Restoration in Patients With DCM Undergoing Open-heart Surgery
Condition: Dilated Cardiomyopathy
Intervention: Device: Algisyl-LVR
37 Unknown  The Genetics of Dilated Cardiomyopathy: A Quebec-Based Study
Condition: Dilated Cardiomyopathy (DCM)
Intervention: Other: blood test
38 Terminated Optimized Biventricular Pacing Allograft Recipients
Conditions: Dilated Cardiomyopathy;   Ischemic Cardiomyopathy
Interventions: Device: BiVP;   Device: AAI Pacing
39 Active, not recruiting The Genetics of Cardiomyopathy and Heart Failure
Conditions: Dilated Cardiomyopathy;   Hypertrophic Cardiomyopathy;   Mitochondrial Cardiomyopathy;   Noncompaction Cardiomyopathy;   Restrictive Cardiomyopathy
Intervention:
40 Unknown  Harefield Recovery Protocol Study for Patients With Refractory Chronic Heart Failure
Conditions: Heart Failure;   Dilated Cardiomyopathy
Intervention: Drug: clenbuterol

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years